Julia Chisholm is an expert in Oncology at Royal Marsden Hospital (United Kingdom). As of October 2026, ScienceLeadR ranks Julia Chisholm in the top 1% of experts worldwide for Sarcoma. Julia Chisholm has authored 219 publications, the most recent in 2026, and is an investigator in 11 clinical trials. SLR score: 778 (community average: 125). How the SLR is computed.

LeadR Profile

Julia Chisholm Royal Marsden Hospital United Kingdom
778 ScienceLeadR Reputation 778
Network Map

Oncology

Subspecialties: Pediatrics - Radiotherapy - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Royal Marsden Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 219

Citations

Citations: 6 640 1st author: 35 Last author: 20 Unique author: 19


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experience.
PMID 42944591 — rhabdomyosarcoma, incidence, cyclophosphamide, neoplasms, drug therapy, maintenance, sarcoma, maintenance chemotherapy, neoplasms, second primary, neurofibromatosis 1, therapeutics, tissues, chemotherapy
Cancer20260
Does Current United Kingdom Childhood Cancer Research Address the James Lind Alliance Children's Cancer Priority Setting Partnership Priorities? A Grant Mapping Study.
PMID 42649119 — neoplasms, health services research, research, therapeutics, child
Health Expect20260
The impact of whole lung irradiation in lung metastatic rhabdomyosarcoma: A pooled analysis of two European trials and one European registry.
PMID 42490727 — registries, lung, rhabdomyosarcoma, neoplasms, metastasectomy, sarcoma, neoplasm metastasis, therapeutics
Cancer20260
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.
PMID 42288687 — cells, rhabdomyosarcoma, antigens, surface, pharmaceutical preparations, neoplasms, sarcoma, therapeutics, child
Br J Cancer20260
Highly conformal whole abdominopelvic radiotherapy: Consensus delineation guidelines from EpSSG and QUARTET.
PMID 42119643 — radiotherapy, urinary bladder, sarcoma, peritoneum
Radiother Oncol20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 2 4
Phase 1/Phase 2 2
Phase 3 2
N/A 1
Phase 1 1
Phase 4 1

By status:

Completed 5
Unknown 3
Recruiting 2
Terminated 1

By type:

Interventional 11

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map